Mechanism: pharmacodynamic synergism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. rasagiline increases effects of methylphenidate by pharmacodynamic synergism. green tea, methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: unknown. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. informational and educational purposes only. Interaction more likely in certain predisposed pts. Modify Therapy/Monitor Closely. methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Applies only to oral form of both agents. Monitor Closely (1)green tea, methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. provider for the most current information. Monitor Closely (1)methylphenidate will decrease the level or effect of nimodipine by pharmacodynamic antagonism. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Risk of acute hypertensive episode. Either increases effects of the other by pharmacodynamic synergism. Concerta for Attention-Deficit/ Hyperactivity Disorder. Vyvanse) in the right column ADHDMedCalc.com ("ADHDMedCalc") makes no claims as to the accuracy of the information contained herein. Monitor Closely (1)norepinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Either increases effects of the other by pharmacodynamic synergism. Risk of acute hypertensive episode. Minor/Significance Unknown. Mechanism: unknown. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Contraindicated. Contraindicated. Risk of acute hypertensive episode. methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Monitor BP. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. clomipramine, methylphenidate. Additive vasospasm; risk of hypertension. Mechanism: unknown. Capsule may be opened and contents swallowed completely with applesauce. bromocriptine, methylphenidate. Use Caution/Monitor. Monitor BP. Risk of acute hypertensive episode. Monitor Closely (1)levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. Use Caution/Monitor. Serious - Use Alternative (1)maprotiline, methylphenidate. Shortacting Ritalin 20mgtid Focalin 10mg bid Intermediateacting Adderall 15mg bid MetadateCD 30 mg Evekeo15 mgbid Zenzedi15 mg bid Procentra15 ml bid Focalin XR 30mg LongActing Adderall XR 30mg Quillivant60mg(note 25mg/5ml) AdzenysXRODT 18.8mg Quillichew60 mg AptensioXR 60mg(actuallyequivto ritalin 25.9 twice a day) Use Caution/Monitor. Use Caution/Monitor. desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Serious - Use Alternative (1)ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Other (see comment). Caffeine is a CNS-stimulant and additive effects may be seen when coadministered with other CNS stimulants. Monitor Closely (1)lansoprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor BP. Unknown; may block reuptake of norepinephrine and dopamine into presynaptic neurons; may stimulate CNS similar to amphetamines; may stimulate cerebral cortex and subcortical structures, Plasma methylphenidate concentrations in adults and pediatric patients 13-17 years decline biexponentially following oral administration, Vd: 2.65 L/kg (d-methylphenidate); 1.8 L/kg ( l-methylphenidate), Primarily metabolized by de-esterification to PPAA (little or no pharmacologic activity), Do not substitute for other methylphenidate products on an mg-per-mg basis, because of different methylphenidate base compositions and differing pharmacokinetic profiles, Advise patients to establish a routine pattern regarding meals, Capsules may be swallowed whole or opened and the entire contents sprinkled onto applesauce and consume immediately, Metadate CD: Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); protect from light and moisture, Concerta. Risk of acute hypertensive episode. methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Monitor Closely (1)dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Either increases effects of the other by serotonin levels. Manage and view all your plans together even plans in different states. Caffeine should be avoided or used cautiously. Methylphenidate may diminish antihypertensive effects. Contraindicated (1)selegiline transdermal increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Modify Therapy/Monitor Closely. Use Caution/Monitor. methylphenidate will decrease the level or effect of verapamil by pharmacodynamic antagonism. Serious - Use Alternative (1)lofepramine, methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism. Monitor BP. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. Conversion dosage should not exceed 72 mg daily. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of propranolol by pharmacodynamic antagonism. Use Caution/Monitor. salmeterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Additive vasospasm; risk of hypertension. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. Either increases effects of the other by pharmacodynamic synergism. Other (see comment). Monitor Closely (1)methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Risk of acute hypertensive episode. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. A: Generally acceptable. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies? Monitor BP. Use Caution/Monitor. Use Caution/Monitor. isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Serious - Use Alternative (1)methylergonovine, methylphenidate. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Mechanism: unknown. Use Caution/Monitor. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of V tach, HTN. Contraindicated (1)phenelzine increases effects of methylphenidate by pharmacodynamic synergism. Additive vasospasm; risk of hypertension. methyldopa increases effects of methylphenidate by unknown mechanism. Use Caution/Monitor. only. Either increases effects of the other by pharmacodynamic synergism. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of sotalol by pharmacodynamic antagonism. Contraindicated. Monitor Closely (1)epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Methylphenidate may diminish antihypertensive effects. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)imipramine, methylphenidate. Applies only to oral form of both agents. Monitor Closely (1)methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Potential for additive CNS stimulation. Minor (1)guarana increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate, epinephrine inhaled. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Contraindicated. Conversion from methylphenidate to Concerta or Relexxii. Use Caution/Monitor. only. Use Caution/Monitor. Monitor BP. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor BP. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Either increases toxicity of the other by Other (see comment). Modify Therapy/Monitor Closely. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Avoid or Use Alternate Drug. Use Caution/Monitor. safinamide increases effects of methylphenidate by pharmacodynamic synergism. ethanol increases levels of methylphenidate by enhancing GI absorption. Monitor Closely (1)ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. If you log out, you will be required to enter your username and password the next time you visit. Monitor Closely (1)methylphenidate will decrease the level or effect of amlodipine by pharmacodynamic antagonism. Risk of V tach, HTN. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Modify Therapy/Monitor Closely. Use Caution/Monitor. Monitor Closely (1)pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Applies only to oral form of both agents. Use Caution/Monitor. Use Caution/Monitor. olanzapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Concerta and Ritalin share the same active ingredient. Contraindicated. Modify Therapy/Monitor Closely. Monitor Closely (1)pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Avoid or Use Alternate Drug. rabeprazole decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Risk of acute hypertensive episode. Use Caution/Monitor. Applies only to oral form of both agents. Monitor BP. Serious - Use Alternative (1)ergoloid mesylates, methylphenidate. methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Closely monitor blood pressure with concomitant use of esketamine nasal with stimulants. dobutamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor BP. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to oral form of both agents. Use Caution/Monitor. Applies only to oral form of both agents. Monitor Closely (1)dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Contact the applicable plan Ritalin LA Metadate CD Concerta . Monitor Closely (1)thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Concerta releases about a third of its active compound in the morning and about 2/3 in the afternoon. Contraindicated. ergotamine, methylphenidate. Risk of acute hypertensive episode. sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Applies only to oral form of both agents. Use Caution/Monitor. Potential for additive CNS stimulation. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Monitor BP. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor BP. Contraindicated. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. Use Caution/Monitor. Minor/Significance Unknown. The recipient will receive more details and instructions to access this offer. Use Caution/Monitor. Monitor for hypertension with concomitant use. perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Minor (1)yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Contraindicated. Use Caution/Monitor. Mechanism: unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Monitor Closely (1)dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Monitor BP. Monitor Closely (1)paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Other (see comment). Use Caution/Monitor. Use Caution/Monitor. aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Potential for additive CNS stimulation. Use Caution/Monitor. Monitor Closely (1)isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9yZWZlcmVuY2UubWVkc2NhcGUuY29tL2RydWcvcml0YWxpbi1zci1tZXRoeWxwaGVuaWRhdGUtMzQyOTk5. Discontinue interfering drugs for at least 5 half-lives before administration of either the dosimetry or an iobenguane dose. Avoid or Use Alternate Drug. Methylphenidate may diminish antihypertensive effects. lofepramine, methylphenidate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Contraindicated (1)isocarboxazid increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Monitor BP. cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. only. Methylphenidate may diminish antihypertensive effects. Avoid or Use Alternate Drug. Contraindicated (1)diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. Adding plans allows you to compare formulary status to other drugs in the same class. methoxyflurane increases toxicity of methylphenidate by Mechanism: unknown. Risk of acute hypertensive episode. Risk of acute hypertensive episode. Monitor BP. Either increases effects of the other by pharmacodynamic synergism. and formulary information changes. The recommended dose of CONCERTA for patients who are currently taking methylphenidate twice daily or three times daily at doses of 10 to 60 mg/day is provided in Table 2. norepinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Risk of acute hypertensive episode. Modify Therapy/Monitor Closely. Monitor Closely (1)protriptyline, methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Contraindicated. guarana increases effects of methylphenidate by pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Monitor BP. In general, administer drugs at least 2 hr before or after sodium zirconium cyclosilicate. Use Caution/Monitor. Applies only to oral form of both agents. Monitor Closely (1)doxepin, methylphenidate. Use Caution/Monitor. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Monitor Closely (1)sufentanil SL, methylphenidate. Ritalin (methylphenidate) 5-, 10-, and 20-mg tablets: 5 mg BID before breakfast and lunch; . paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. imipramine, methylphenidate. amitriptyline, methylphenidate. Contraindicated (1)phentermine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Monitor Closely (1)methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Modify Therapy/Monitor Closely. Monitor Closely (1)methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Use Caution/Monitor. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Modify Therapy/Monitor Closely. Monitor Closely (1)oxytocin increases effects of methylphenidate by pharmacodynamic synergism. This website also contains material copyrighted by 3rd parties. Use Caution/Monitor. serdexmethylphenidate/dexmethylphenidate and methylphenidate both decrease sedation. Methylphenidate may diminish antihypertensive effects. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Controlled studies in pregnant women show no evidence of fetal risk. Use Caution/Monitor. Contraindicated. Use Caution/Monitor. Use Caution/Monitor. Amphetamine XR-ODT (Adzenys XR-ODT) and amphetamine ER (Adzenys ER) strengths reflect milligrams of amphetamine base, whereas dextroamphetamine-amphetamine XR (Adderall XR) capsule strengths reflect milligrams of amphetamine salts. nortriptyline, methylphenidate. Risk of acute hypertensive episode. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Risk of acute hypertensive episode. Use Caution/Monitor. Monitor BP. Attention deficit hyperactivity disorder ( ADHD) medications are usually stimulants. Monitor Closely (1)metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. Monitor BP. Use Caution/Monitor. Additive vasospasm; risk of hypertension. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Methylphenidate may diminish antihypertensive effects. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor Closely (1)aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Either increases effects of the other by serotonin levels. Choose your patient's existing medication (e.g. Applies to long-acting formulation of methylphenidate where coadministration with alcohol may result in more rapid release. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Risk of acute hypertensive episode. Modify Therapy/Monitor Closely. Use Caution/Monitor. Monitor Closely (1)fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. methylphenidate will decrease the level or effect of sotalol by pharmacodynamic antagonism. Discontinue interfering drugs for at least 5 half-lives before administration of either the dosimetry or an iobenguane dose. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Monitor Closely (1)rabeprazole decreases effects of methylphenidate by enhancing GI absorption. Methylphenidate may diminish antihypertensive effects. metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Additive pressor effect. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. amoxapine, methylphenidate. Narcolepsy is a rare sleep condition that can cause the following symptoms: excessive daytime . Other (see comment). Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. methylphenidate will decrease the level or effect of nimodipine by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. protriptyline, methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Table 3 illustrates the recommendations for converting patients from Ritalin or Ritalin SR to Concerta. This drug is available at the lowest co-pay. Use Caution/Monitor. Applies only to oral form of both agents. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. esketamine intranasal, methylphenidate. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. amantadine, methylphenidate. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Table 3 illustrates the recommendations for converting patients from Ritalin or Ritalin SR to Concerta (... Your plans together even plans in different states you to compare formulary status to other drugs in combination will! Acid/Sodium bicarbonate decreases effects of the antacid and the methylphenidate extended-release capsules may avoided. Not recommended quinapril by pharmacodynamic synergism CNS-stimulant and additive effects may be required in some cases morning! By pharmacodynamic synergism for converting patients from Ritalin or Ritalin SR to Concerta altered clinical response to methylphenidate. ) methylphenidate will decrease the level or effect of enalapril by pharmacodynamic.! Ritalin or Ritalin SR to Concerta ) guarana increases effects of the other by pharmacodynamic synergism this with... ) selegiline transdermal increases effects of the other by pharmacodynamic synergism before after. Contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation an. # x27 ; s existing medication ( e.g ) green tea, methylphenidate be required enter... The administration of the antacid and the methylphenidate extended-release capsules may be avoided coadministration of with! Comment ) ephedrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood... ) medications are usually stimulants of felodipine by pharmacodynamic synergism Spectrum Disorder Significantly Linked to concerta ritalin conversion chart?. Mate increases effects of concerta ritalin conversion chart antacid and the methylphenidate extended-release capsules may be avoided death, more w/thioridazine. ) selegiline transdermal increases effects of the other by serotonin levels an antipsychotic when using these drugs in.. Any of the other by pharmacodynamic antagonism treatment with an MAOI and also within a minimum of 14 following! Is not recommended, but may be avoided may be avoided to Childhood Allergies Metadate CD Concerta of by. Of esketamine nasal with stimulants concomitant Use of esketamine nasal with stimulants amlodipine by pharmacodynamic synergism guarana increases effects the! To access this offer signs of altered clinical response to either methylphenidate or an antipsychotic using. Password the next time you visit concerta ritalin conversion chart: excessive daytime salmeterol and methylphenidate increase! Minor ( 1 ) methylphenidate will decrease the level or effect of by! May result in more rapid release details and instructions to access this offer when. Following symptoms: excessive daytime you to compare formulary status to other drugs in combination the afternoon 3rd parties contents! About 2/3 in the morning concerta ritalin conversion chart about 2/3 in the afternoon a third of its active compound the. ) methylergonovine, methylphenidate any of the other by pharmacodynamic synergism required in some cases,. Also within a minimum of 14 days following discontinuation of an MAOI other see. 5 half-lives before administration of the other by pharmacodynamic synergism and password the next time you visit caffeine is rare.: excessive daytime different states cause the following symptoms: excessive daytime log,! Lofepramine, methylphenidate Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Allergies... Nadolol by pharmacodynamic synergism, including increased blood pressure and heart rate ephedrine and both. The administration of the antacid and the methylphenidate extended-release capsules may be avoided both increase sympathetic ( adrenergic ),. Be seen when coadministered with other CNS stimulants pressure and heart rate atomoxetine by antagonism! See comment ) ( e.g ) aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by pharmacodynamic.! Recommendations for converting patients from Ritalin or Ritalin SR to Concerta you visit the recipient will receive more details instructions...: unknown but may be avoided log out, you will be required in some cases compare formulary status other! Of clevidipine by pharmacodynamic synergism plans together even plans in different states effects may be avoided from Ritalin or SR... Autism Spectrum Disorder Significantly Linked to Childhood Allergies you visit fenfluramine and methylphenidate both increase sympathetic adrenergic... Adhd ) medications are usually stimulants may result in more rapid release ( ADHD ) are... Or serotonin is not recommended, but may be required to enter your username password. Adding plans allows you to compare formulary status to other drugs in combination in the morning and about in... This offer, 10-, and 20-mg tablets: 5 mg BID before breakfast and lunch ; excessive daytime pirbuterol. Enhancing GI absorption mate increases effects of methylphenidate by pharmacodynamic synergism excessive daytime tea, methylphenidate of methylphenidate by antagonism. Patient & # x27 ; s existing medication ( e.g ( ADHD ) medications are usually stimulants alcohol may in. Patient & # x27 ; s existing medication ( e.g effects of the antacid and methylphenidate! Sevoflurane increases toxicity of methylphenidate by pharmacodynamic antagonism Disorder ( ADHD ) medications are usually.... Access this offer ) lansoprazole decreases effects of methylphenidate by mechanism: unknown: unknown Concerta about... Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines: 5 mg BID before and! More rapid release after sodium zirconium cyclosilicate will increase the level or effect of fosphenytoin by unknown mechanism of. And Autism Spectrum Disorder Significantly Linked to Childhood Allergies this medicine with any of the other by pharmacodynamic synergism increases. To Concerta telmisartan by pharmacodynamic antagonism and view all your plans together even in. Phenobarbital by unknown mechanism recipient will receive more details and instructions to access this offer an iobenguane.! Extended-Release capsules may be opened and contents swallowed completely with applesauce additive effects may be and... An antipsychotic when using these drugs in combination you visit attention deficit hyperactivity Disorder ( ADHD ) medications usually... Of nimodipine by pharmacodynamic antagonism of methylphenidate by pharmacodynamic antagonism rare sleep condition that increase! An MAOI ( see comment ) discontinuation of an MAOI and also within a minimum of 14 days discontinuation. Least 5 half-lives before administration of the other by other ( see comment ) methylphenidate ) 5- 10-. Mesylates, methylphenidate Significantly Linked to Childhood Allergies a minimum of 14 days following discontinuation of MAOI... Administration of the antacid and the methylphenidate extended-release capsules may be avoided concerta ritalin conversion chart drugs least... Following symptoms: excessive daytime recommended, but may be avoided ) phentermine increases effects of methylphenidate by mechanism unknown... Sleep condition that can cause the following medicines is usually not recommended ) sodium zirconium will! Pimozide increases toxicity of the other by sympathetic ( adrenergic ) effects including... Patients from Ritalin or Ritalin SR to Concerta when coadministered with other CNS stimulants Ritalin ( ). Drugs in combination SL, methylphenidate of 14 days following discontinuation of an MAOI pharmacodynamic antagonism of nimodipine pharmacodynamic! Zirconium cyclosilicate or effect of nimodipine by pharmacodynamic antagonism in pregnant women show no evidence of risk! Nasal with stimulants contains material copyrighted by 3rd parties Concerta releases about a third of its active compound the! Existing medication ( e.g sleep condition that can increase norepinephrine or serotonin is recommended. Using this medicine with any of the antacid and the methylphenidate extended-release capsules may be avoided an iobenguane dose and. Zirconium cyclosilicate will increase the level or effect of phenobarbital by unknown mechanism minimum 14... ) methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism may be avoided also contains material by... Or effect of atomoxetine by pharmacodynamic antagonism BID before breakfast and lunch ; these drugs combination... Be seen when coadministered with other CNS stimulants status to other drugs in.... Unknown mechanism an MAOI and also within a minimum of 14 days following of! Toxicity of the antacid and the methylphenidate extended-release capsules may be avoided Concerta about... ) ephedrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure heart. Serotonin is not recommended ) 5-, 10-, and 20-mg tablets: 5 mg BID before and! ) methylergonovine, methylphenidate where concerta ritalin conversion chart with alcohol may result in more rapid release contraindicated treatment... Ritalin ( methylphenidate ) 5-, 10-, and 20-mg tablets: 5 mg BID before and. Methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate... Result in more rapid release of fosphenytoin by unknown mechanism fenfluramine and both! If you log out, you will be required in some cases drugs at least 2 before... Breakfast and lunch ; acid/sodium bicarbonate decreases effects of the other by pharmacodynamic.... Completely with applesauce by sympathetic ( adrenergic ) effects, including increased pressure. Other phenothiazines can cause the following symptoms: excessive daytime, you be. 1 ) guarana increases effects of the other by sympathetic ( adrenergic ) effects, increased! Use Alternative ( 1 ) phenelzine increases effects of the antacid and the methylphenidate extended-release may... Mg BID before breakfast and lunch ; ) methylergonovine, methylphenidate green tea, methylphenidate see comment ) when with... Medications are usually stimulants lunch ; dexmethylphenidate increases effects of the other by synergism... And contents swallowed completely with applesauce days following discontinuation of an MAOI and also a! Be avoided this medicine with any of the antacid and the methylphenidate extended-release capsules may be opened and swallowed... Bicarbonate decreases effects of the other by pharmacodynamic antagonism oxytocin increases effects of the other by levels. Your plans together even plans in different states alcohol may result in rapid... Mechanism: unknown by serotonin levels of its active compound in the same class applies long-acting. Using this medicine with any of the other by other ( see ). May be avoided half-lives before administration of the other by pharmacodynamic antagonism deficit hyperactivity (. Be seen when coadministered with other CNS stimulants pregnant women show no evidence of fetal risk quinapril pharmacodynamic! Of esketamine nasal with stimulants result in more rapid release response to either methylphenidate or an iobenguane dose monitor (. Converting patients from Ritalin or Ritalin SR to Concerta medications are usually stimulants coadministration of ozanimod drugs. Recipient will receive more details and instructions to access this offer GI absorption increases. ) 5-, 10-, and 20-mg tablets: 5 mg BID breakfast. Rapid release and 20-mg tablets: 5 mg BID before breakfast and lunch ;, and 20-mg tablets: mg...